Inhibition of Glioma Development by ASCL1-Mediated Direct Neuronal Reprogramming

Inhibition of Glioma Development by ASCL1-Mediated Direct Neuronal Reprogramming

Direct conversion of non-neural cells into induced neurons holds great promise for brain repair. As the most common malignant tumor in the central nervous system, glioma is currently incurable due to its exponential growth and invasive behavior. Given that neurons are irreversible postmitotic cells,...

Full description

Bibliographic Details
Main Authors:	Xueyan Cheng, Zijian Tan, Xiao Huang, Yimin Yuan, Shangyao Qin, Yakun Gu, Dan Wang, Cheng He, Zhida Su
Format:	Article
Language:	English
Published:	MDPI AG 2019-06-01
Series:	Cells
Subjects:	ASCL1 reprogramming glioma cells neurons
Online Access:	https://www.mdpi.com/2073-4409/8/6/571

Similar Items

Elevated ASCL1 activity creates de novo regulatory elements associated with neuronal differentiation
by: Laura M. Woods, et al.
Published: (2022-04-01)

Direct Neuronal Reprogramming of Common Marmoset Fibroblasts by ASCL1, microRNA-9/9*, and microRNA-124 Overexpression
by: Akisa Nemoto, et al.
Published: (2020-12-01)

Ascl1 phospho-status regulates neuronal differentiation in a Xenopus developmental model of neuroblastoma
by: Luke A. Wylie, et al.
Published: (2015-05-01)

ASCL2 is a key regulator of the proliferation–differentiation equilibrium in the esophageal epithelium
by: Maude Hamilton, et al.
Published: (2024-01-01)

Direct Reprogramming of Adult Human Somatic Stem Cells Into Functional Neurons Using Sox2, Ascl1, and Neurog2
by: Jessica Alves de Medeiros Araújo, et al.
Published: (2018-06-01)

MicroRNAs and Ascl1 facilitate direct conversion of porcine fibroblasts into induced neurons
by: Mette Habekost, et al.
Published: (2020-10-01)

Histone H3.3 K27M chromatin functions implicate a network of neurodevelopmental factors including ASCL1 and NEUROD1 in DIPG
by: Nichole A. Lewis, et al.
Published: (2022-05-01)

The Potential of Targeting Brain Pathology with Ascl1/Mash1
by: Bor Luen Tang
Published: (2017-08-01)

The proneural transcription factor ASCL1 regulates cell proliferation and primes for differentiation in neuroblastoma
by: Lydia M. Parkinson, et al.
Published: (2022-10-01)

The Analysis of the Foxp2 and ASCL1 Expression in Saffron-Treated Mice
by: Syavash Yazdian, et al.
Published: (2023-07-01)

Polymorphism in ASCL1 target gene DDC is associated with clinical outcomes of small cell lung cancer patients
by: Ji Hyun Kim, et al.
Published: (2020-01-01)

Evidence of Müller Glia Conversion Into Retina Ganglion Cells Using Neurogenin2
by: Roberta Pereira de Melo Guimarães, et al.
Published: (2018-11-01)

DPEP1 promotes drug resistance in colon cancer cells by forming a positive feedback loop with ASCL2
by: Cheng Zeng, et al.
Published: (2023-01-01)

ASCL1 Is Involved in the Pathogenesis of Schizophrenia by Regulation of Genes Related to Cell Proliferation, Neuronal Signature Formation, and Neuroplasticity
by: Dmitrii A. Abashkin, et al.
Published: (2023-10-01)

Transcription factor-based gene therapy to treat glioblastoma through direct neuronal conversion
by: Xin Wang, et al.
Published: (2021-08-01)

Global DNA methylation remodeling during direct reprogramming of fibroblasts to neurons
by: Chongyuan Luo, et al.
Published: (2019-01-01)

Specific Labeling of Stem Cell Activity in Human Colorectal Organoids Using an ASCL2-Responsive Minigene
by: Koen C. Oost, et al.
Published: (2018-02-01)

ASCL1 promotes Scrt2 expression in the neural tube
by: Carolina Purcell Goes, et al.
Published: (2024-04-01)

Application of Small Molecules in the Central Nervous System Direct Neuronal Reprogramming
by: Jingyi Wang, et al.
Published: (2022-07-01)

Ascl1 phospho-site mutations enhance neuronal conversion of adult cortical astrocytes in vivo
by: Hussein Ghazale, et al.
Published: (2022-08-01)

Direct Reprogramming of Spiral Ganglion Non-neuronal Cells into Neurons: Toward Ameliorating Sensorineural Hearing Loss by Gene Therapy
by: Teppei Noda, et al.
Published: (2018-02-01)

Promoters of ASCL1‐ and NEUROD1‐dependent genes are specific targets of lurbinectedin in SCLC cells
by: Federico Costanzo, et al.
Published: (2022-04-01)

Regeneration of the cerebral cortex by direct chemical reprogramming of macrophages into neuronal cells in acute ischemic stroke
by: Itaru Ninomiya, et al.
Published: (2023-08-01)

Targeting PTB for Glia-to-Neuron Reprogramming In Vitro and In Vivo for Therapeutic Development in Neurological Diseases
by: Matilde Contardo, et al.
Published: (2022-02-01)

Corrigendum: Regeneration of the cerebral cortex by direct chemical reprogramming of macrophages into neuronal cells in acute ischemic stroke
by: Itaru Ninomiya, et al.
Published: (2024-02-01)

ASCL1 and DLL3 expressions and their clinicopathological implications in surgically resected pure small cell lung cancer: A study of 247 cases from the National Cancer Center of China
by: Chunfang Hu, et al.
Published: (2022-02-01)

Post-transcriptional mechanisms controlling neurogenesis and direct neuronal reprogramming
by: Elsa Papadimitriou, et al.
Published: (2024-01-01)

Direct Neuronal Reprogramming Reveals Unknown Functions for Known Transcription Factors
by: Gaia Colasante, et al.
Published: (2019-03-01)

Transcriptome Analysis of Small Molecule–Mediated Astrocyte-to-Neuron Reprogramming
by: Ning-Xin Ma, et al.
Published: (2019-05-01)

Direct neuronal reprogramming for central nervous system regeneration
by: Peng‐Yuan Wang, et al.
Published: (2023-09-01)

Induced Neurons for Disease Modeling and Repair: A Focus on Non-fibroblastic Cell Sources in Direct Reprogramming
by: Kathryn M. Kim, et al.
Published: (2021-03-01)

Current Approaches and Molecular Mechanisms for Directly Reprogramming Fibroblasts Into Neurons and Dopamine Neurons
by: Fabin Han, et al.
Published: (2021-09-01)

Deletion of Ascl1 in pancreatic β-cells improves insulin secretion, promotes parasympathetic innervation, and attenuates dedifferentiation during metabolic stress
by: Anna B. Osipovich, et al.
Published: (2023-12-01)

Reprogramming glioblastoma multiforme cells into neurons by protein kinase inhibitors
by: Jie Yuan, et al.
Published: (2018-08-01)

New Insights into the Multifaceted Role of Myeloid-Derived Suppressor Cells (MDSCs) in High-Grade Gliomas: From Metabolic Reprograming, Immunosuppression, and Therapeutic Resistance to Current Strategies for Targeting MDSCs
by: Senthilnath Lakshmanachetty, et al.
Published: (2021-04-01)

Parkinson's disease motor symptoms rescue by CRISPRa‐reprogramming astrocytes into GABAergic neurons
by: Jessica Giehrl‐Schwab, et al.
Published: (2022-05-01)

Overexpression of the proneural transcription factor ASCL1 in chronic lymphocytic leukemia with a t(12;14)(q23.2;q32.3)
by: Theodora Malli, et al.
Published: (2018-01-01)

How to reprogram human fibroblasts to neurons
by: Ziran Xu, et al.
Published: (2020-10-01)

Protocol Optimization for Direct Reprogramming of Primary Human Fibroblast into Induced Striatal Neurons
by: Nina Kraskovskaya, et al.
Published: (2023-04-01)

Direct Neuronal Reprogramming: Bridging the Gap Between Basic Science and Clinical Application
by: Lakshmy Vasan, et al.
Published: (2021-07-01)